Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cempra Inc (NASDAQ:CEMP)

3.80
Delayed Data
As of Apr 24
 0.00 / 0.00%
Today’s Change
2.55
Today|||52-Week Range
26.95
+35.71%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$201.7M

Company Description

Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC.

Contact Information

Cempra, Inc.
Building Two Quadrangle
Chapel Hill North Carolina 27517
P:(919) 313-6601
Investor Relations:

Employees

Shareholders

Mutual fund holders33.52%
Other institutional23.09%
Individual stakeholders14.42%

Top Executives

David ZaccardelliChief Executive Officer & Director
David S. MoorePresident & Chief Commercial Officer
Mark W. HahnChief Financial Officer & Executive Vice President
David OldachChief Medical Officer
David PereiraSenior Vice President